A Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment

Recruiting now · Phase 1

Conditions studied: Patients With Mild or Moderate Hepatic Impairment

In brief

An open-label study to evaluate the effect of TS-172 administration on pharmacokinetics in patients with hepatic impairment

Key facts

Study ID
NCT07231029
Run by
Taisho Pharmaceutical Co., Ltd.
People needed
24
Starts
2025-12-23
Expected to finish
2026-10-31
Last updated by the study team
2026-01-09

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.